Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 122

1.

Early hospital discharge of infants born to group B streptococci-positive mothers: a decision analysis.

Berger MB, Xu X, Williams JA, Van de Ven CJ, Mozurkewich EL.

BJOG. 2012 Mar;119(4):439-48. doi: 10.1111/j.1471-0528.2011.03249.x. Epub 2012 Jan 18.

2.

Cost-effectiveness of universal prophylaxis in pregnancy with prior group B streptococci colonization.

Turrentine MA, Ramirez MM, Mastrobattista JM.

Infect Dis Obstet Gynecol. 2009;2009:934698. doi: 10.1155/2009/934698. Epub 2009 Dec 13.

3.
5.

Cost-effectiveness of different treatment strategies with intrapartum antibiotic prophylaxis to prevent early-onset group B streptococcal disease.

Akker-van Marle ME, Rijnders ME, Dommelen P, Fekkes M, Wouwe JP, Amelink-Verburg MP, Verkerk PH.

BJOG. 2005 Jun;112(6):820-6.

6.

Early-onset group B streptococcal disease in the era of maternal screening.

Puopolo KM, Madoff LC, Eichenwald EC.

Pediatrics. 2005 May;115(5):1240-6.

PMID:
15867030
7.

Preventing early-onset group B streptococcal sepsis: strategy development using decision analysis.

Benitz WE, Gould JB, Druzin ML.

Pediatrics. 1999 Jun;103(6):e76.

PMID:
10353973
8.

Clinical and economic outcomes for term infants associated with increasing administration of antibiotics to their mothers.

Glasgow TS, Speakman M, Firth S, James B, Byington CL, Young PC.

Paediatr Perinat Epidemiol. 2007 Jul;21(4):338-46.

PMID:
17564591
9.

Cost-effectiveness of a potential group B streptococcal vaccine program for pregnant women in South Africa.

Kim SY, Russell LB, Park J, Verani JR, Madhi SA, Cutland CL, Schrag SJ, Sinha A.

Vaccine. 2014 Apr 7;32(17):1954-63. doi: 10.1016/j.vaccine.2014.01.062. Epub 2014 Feb 11.

PMID:
24530145
10.

The use of blood counts and blood cultures to screen neonates born to partially treated group B Streptococcus-carrier mothers for early-onset sepsis: is it justified?

Hashavya S, Benenson S, Ergaz-Shaltiel Z, Bar-Oz B, Averbuch D, Eventov-Friedman S.

Pediatr Infect Dis J. 2011 Oct;30(10):840-3. doi: 10.1097/INF.0b013e3182223586.

PMID:
21617574
11.

Perinatal screening for group B streptococci: cost-benefit analysis of rapid polymerase chain reaction.

Haberland CA, Benitz WE, Sanders GD, Pietzsch JB, Yamada S, Nguyen L, Garber AM.

Pediatrics. 2002 Sep;110(3):471-80.

PMID:
12205247
12.
13.
14.

Intrapartum evidence of early-onset group B streptococcus.

Tudela CM, Stewart RD, Roberts SW, Wendel GD Jr, Stafford IA, McIntire DD, Sheffield JS.

Obstet Gynecol. 2012 Mar;119(3):626-9. doi: 10.1097/AOG.0b013e31824532f6.

PMID:
22353962
15.

Comparison of prevention strategies for neonatal group B streptococcal infection. A population-based economic analysis.

Mohle-Boetani JC, Schuchat A, Plikaytis BD, Smith JD, Broome CV.

JAMA. 1993 Sep 22-29;270(12):1442-8.

PMID:
8371444
16.

Cost-effectiveness of rapid tests and other existing strategies for screening and management of early-onset group B streptococcus during labour.

Kaambwa B, Bryan S, Gray J, Milner P, Daniels J, Khan KS, Roberts TE.

BJOG. 2010 Dec;117(13):1616-27. doi: 10.1111/j.1471-0528.2010.02752.x.

17.

Group B streptococcus: to culture or not to culture?

Katz PF, Hibbard JU, Ranganathan D, Meadows W, Ismail M.

J Perinatol. 1999 Jul-Aug;19(5):337-42.

PMID:
10685253
18.

Early-onset group B streptococcal infection after a combined maternal and neonatal group B streptococcal chemoprophylaxis strategy.

Velaphi S, Siegel JD, Wendel GD Jr, Cushion N, Eid WM, Sánchez PJ.

Pediatrics. 2003 Mar;111(3):541-7.

PMID:
12612234
19.

Reduction of the use of antimicrobial drugs following the rapid detection of Streptococcus agalactiae in the vagina at delivery by real-time PCR assay.

Poncelet-Jasserand E, Forges F, Varlet MN, Chauleur C, Seffert P, Siani C, Pozzetto B, Ros A.

BJOG. 2013 Aug;120(9):1098-108. doi: 10.1111/1471-0528.12138. Epub 2013 May 8.

20.

Supplemental Content

Support Center